Cargando…

SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a progressive chronic disease associated with severe microvascular and macrovascular complications. Our aim is to assess the real world effectiveness of SGT" inhibitors in achieving metabolic therapeutic goals. METHODS: A retrospective, observation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamez-Perez, Héctor Eloy, Delgadillo-Esteban, Enrique, Soni-Duque, David, Hernández-Coria, Mayra Ivonne, Tamez-Peña, Alejandra Lorena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493113/ https://www.ncbi.nlm.nih.gov/pubmed/28680862 http://dx.doi.org/10.1186/s40200-017-0308-4

Ejemplares similares

Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
por: Tamez, Hector E., et al.
Publicado: (2015)

El ABC de la medicina científica
por: Tamez Pérez, Héctor Eloy
Publicado: (2012)

Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
por: Pitt, Bertram, et al.
Publicado: (2022)

OR22-1 Liraglutide as Add-on to SGLT2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes (LIRA-ADD2SGLT2i): A 26-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Blonde, Lawrence, et al.
Publicado: (2019)

Rosiglitazone as an option for patients with acromegaly: a case series
por: Tamez-Pérez, Héctor E, et al.
Publicado: (2011)

Inpatient hyperglycemia: Clinical management needs in teaching hospital()
por: Tamez-Pérez, H.E., et al.
Publicado: (2014)

Modulation of Neural Activity during Guided Viewing of Visual Art
por: Herrera-Arcos, Guillermo, et al.
Publicado: (2017)

SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits
por: Leoncini, Giovanna, et al.
Publicado: (2021)

A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
por: Liu, Allen Yan Lun, et al.
Publicado: (2022)

Real-Time Strap Pressure Sensor System for Powered Exoskeletons
por: Tamez-Duque, Jesús, et al.
Publicado: (2015)

Principios de diseño y construcción de presas de tierra
por: Támez González, Enrique
Publicado: (1964)

Ingeniería de cimentaciones : conceptos básicos de la práctica
por: Tamez González, Enrique
Publicado: (2001)

Diseño geotécnico de túneles
por: Tamez González, Enrique
Publicado: (1997)

Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
por: Jeong, Su Jin, et al.
Publicado: (2021)

What Does SGLT2 Inhibition Add in Managing Hyponatremia Secondary to Syndrome of Inappropriate Antidiuresis (SIAD)?
por: Jalal, Fadzliana Hanum, et al.
Publicado: (2021)

Los monstruos del silencio : serial sobre la historia del cine mudo alemán /
por: Martínez Tamez, Héctor, 1936-
Publicado: (1980)

Real‐world data on eslicarbazepine acetate as add‐on to antiepileptic monotherapy
por: Holtkamp, M., et al.
Publicado: (2016)

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use
por: McGovern, Andrew, et al.
Publicado: (2017)

Risk profiles for negative and positive COVID-19 hospitalized patients
por: Nezhadmoghadam, Fahimeh, et al.
Publicado: (2021)

SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?
por: Zayas, Francisco, et al.
Publicado: (2019)

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial
por: Blonde, Lawrence, et al.
Publicado: (2020)

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)
por: McGovern, Andrew, et al.
Publicado: (2017)

SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world
por: Marx, Nikolaus, et al.
Publicado: (2023)

Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol
por: Dorsey-Treviño, Edgar Gerardo, et al.
Publicado: (2018)

SGLT2 inhibitors and amputation risk: Real-world data from a diabetes foot wound clinic
por: Sung, Jasper, et al.
Publicado: (2018)

Use of SGLT2 Inhibitors Reduces Heart Failure and Hospitalization: A Multicenter, Real-World Evidence Study
por: Blanco, Christopher Antonio, et al.
Publicado: (2023)

Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure
por: Nakagaito, Masaki, et al.
Publicado: (2023)

Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
por: Castellana, Marco, et al.
Publicado: (2019)

Evaluating amblyopia during the era of COVID-19
por: Tamez-Tamez, Veronica E., et al.
Publicado: (2020)

Neutral protamine hagedorn/regular insulin in the treatment of inpatient hyperglycemia: Comparison of 3 basal-bolus regimens
por: Quintanilla-Flores, Dania Lizet, et al.
Publicado: (2017)

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
por: Lee, Jiwoo, et al.
Publicado: (2019)

Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes
por: Candido, Riccardo, et al.
Publicado: (2023)

Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2017)

Flexibilidad productiva y accidentes de trabajo : industria automotriz y textil
por: Tamez, Silvia
Publicado: (1993)

Política y corrupción : la crisis de inseguridad en México /
por: Tamez, Macedonio
Publicado: (2016)

Identification of outcome-related driver mutations in cancer using conditional co-occurrence distributions
por: Treviño, Victor, et al.
Publicado: (2017)

Hybrid morphological-convolutional neural networks for computer-aided diagnosis
por: Canales-Fiscal, Martha Rebeca, et al.
Publicado: (2023)

Noninvasive monitoring of liver fat during treatment with GLP‐1 analogues and SGLT‐2 inhibitors in a real‐world setting
por: Mittag‐Roussou, Vasiliki, et al.
Publicado: (2020)

Use of SGLT2i and ARNi in patients with atrial fibrillation and heart failure in 2021–2022: an analysis of real-world data
por: Alonso, Alvaro, et al.
Publicado: (2023)

SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6j9ibsa4cu9qep73jt8g7k8651